BlackRock
MDVX

BlackRock’s Medovex Corp. Common Stock MDVX Stock Holding History

BlackRock’s Portfolio MDVX Stock Details MDVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,961
Closed -$8K – 5076
2017
Q3 		$8K Buy
6,961
+798
+13% +$827 ﹤0.01% 4708
2017
Q2 		$5K Buy
6,163
+1,016
+20% +$1.19K ﹤0.01% 4807
2017
Q1 		$8K Buy
+5,147
New +$6.43K ﹤0.01% 4741

BlackRock's MDVX Position: Q4 2017 in Review

BlackRock sold out of Medovex Corp. Common Stock (MDVX) in Q4 2017, closing a stake of 6,961 shares — an estimated $8K sold.

BlackRock first reported a position in MDVX in Q1 2017 and held it in 3 quarters. The position peaked at $8K in Q3 2017. 0 funds tracked by Wall St. Rank hold MDVX as of Q4 2017.

  • BlackRock reported no remaining Medovex Corp. Common Stock position as of Q4 2017 after selling out during the quarter.
  • BlackRock sold 6,961 Medovex Corp. Common Stock shares in Q4 2017, an estimated $8K.
  • BlackRock first reported a position in Medovex Corp. Common Stock in Q1 2017 and held it in 3 quarters.
  • BlackRock's Medovex Corp. Common Stock position peaked at $8K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Medovex Corp. Common Stock as of Q4 2017.

Based on BlackRock's 13F filing for Q4 2017, filed 9 Feb 2018.